Thermosensitive transient receptor potential (TRP) channels, especially TRPV1 and TRPA1, are activated by the pungent compounds present in spices. TRPV1 activation by the intake of capsaicin, the irritant in hot pepper, induces adrenaline secretion and increases energy consumption. TRPV1 is mainly expressed in the sensory neurons and coexpressed with TRPA1 at a high frequency. However, the mechanism underlying adrenaline secretion by TRPA1 agonists such as allyl isothiocyanate (AITC) and cinnamaldehyde (CNA), the pungent ingredients in mustard and cinnamon, is not known. We examined whether AITC and CNA could induce adrenaline secretion in anesthetized rats. An intravenous injection of AITC or CNA (10 mg/kg) increased adrenaline secretion. These responses disappeared completely in capsaicin-treated rats with an impaired sensory nerve function. Moreover, pretreatment with cholinergic blockers (hexamethonium and atropine) attenuated the AITC-or CNA-induced adrenaline secretion. These results suggest that TRPA1 agonists activate the sensory nerves and induce adrenaline secretion via the central nervous system. Key words: transient receptor potential (TRP) A1; allyl isothiocyanate; cinnamaldehyde; adrenaline; TRPV1
Transient receptor potential A1 (TRPA1) and V1 (TRPV1) are cation channels that belong to the TRP family and are expressed in nociceptive sensory neurons. They are the targets of the pungent compounds in food. TRPA1 is activated by volatile pungent foods such as mustard (allyl isothiocyanate, AITC), 1) cinnamon (cinnamaldehyde, CNA), 2) and garlic (allicin). 3) TRPV1 is activated by hot foods such as hot pepper (capsaicin, CAP), 4) black or white pepper (piperine), 5, 6) and ginger (gingerols and shogaols). 7, 8) Moreover, low or high nociceptive temperatures also affect TRPA1 (<18 C) 2, 9) and TRPV1 (>43 C); 4, 10) therefore, they are called thermosensitive TRP channels.
Activation of TRPV1 plays a role not only in transmission of the pungent or pain sensations but also enhancement of CAP-induced energy consumption and thermogenesis.
11) CAP enhances energy metabolism via adrenaline secretion from the adrenal medulla through activation of the central nervous system. [12] [13] [14] [15] [16] This adrenaline secretion has been inhibited by a pretreatment with pharmacological doses of CAP, which impairs the CAP-sensitive sensory nerve function, 17) and by the TRPV1 antagonist, capsazepine. 18) These results indicate that TRPV1 activation is essential for the adrenaline secretion induced by CAP. Furthermore, adrenaline secretion has been induced by food-derived TRPV1 agonists other than CAP such as piperine, 19) capsiate, 11, 20) capsaicinol, 21) gingerols, and shogaols. 8) It is therefore expected that increasing the energy expenditure with TRPV1 agonists may be an efficient means for preventing or treating obesity. It has been reported that the intake of sweet pepper containing capsiate, which is a CAP analogue and TRPV1 agonist, increased sympathetic nervous activity and suppressed body fat accumulation in humans. 22) There has so far been no report regarding the relationship between TRPA1 activation and energy consumption. TRPA1 appears to be highly coexpressed together with TRPV1 in a subset of small-to mediumdiameter peripheral sensory neurons. 1, 9) Therefore, TRPA1 activation might induce energy expenditure, because TRPV1-expressing sensory nerves are very important for CAP-induced adrenaline secretion and enhanced energy expenditure. 17, 18) We focused in this study on adrenaline secretion as an index of energy metabolism, and examined the effect of the adrenaline secretion induced by the TRPA1 agonist in anesthetized rats. We determined that an intravenous injection of AITC or CNA increased adrenaline secre-tion. However, cinnamyl alcohol and cinnamic acid, which are CNA analogues, did not induce TRPA1 activity and could not enhance adrenaline secretion. Activation of the sensory afferent nerve and adrenal sympathetic efferent nerve was found to be involved in AITC-and CNA-induced adrenaline secretion. These results suggest that TRPA1 activation resulted in energy consumption via the same action mechanism as that for TRPV1 activation.
Materials and Methods
Materials. CAP (>97% pure), atropine (ATR, >97% pure), and hexamethonium bromide (C6) were purchased from Sigma (MO, USA). Trans-cinnamaldehyde (>99% pure), cinnamyl alcohol (CN-OH, 98% pure), and trans-cinnamic acid (CN-acid, >99% pure) were obtained from Aldrich (MO, USA). Allyl isothiocyanate (>99% pure) was purchased from Wako (Osaka, Japan). All other chemicals were of guaranteed reagent grade.
Animals and CAP treatment. Male Sprague-Dawley rats (Japan SLC, Shizuoka, Japan) were housed for at least 1 week under conditions of controlled temperature (23 AE 1 C), humidity (55% AE 5%), and lighting (lights on, 0700-1900 hours); food and water were available ad libitum. Rats which were 7-8 weeks of age (approximately 200-300 g) were used. Animal experimental procedures were approved by the Animal Care and Use Committee of the University of Shizuoka.
The CAP treatment was provided to rats as previously described. 17, 23) Male SD rats (6 weeks old) were administered with a total dose of 310 mg/kg of CAP (10, 20, 30, 50 , 100 and 100 mg/kg/d, s.c.), and 10 and 20 mg/kg/d of CAP was administered under light ether anesthesia. The CAP-treated rats were used for the experiments 3-5 d after the final CAP treatment. On the day of the experiment, we confirmed that these rats did not exhibit any CAP-induced irritant behavior (wiping) by dispensing 15 ml of a 0.5 mM CAP solution into the rat's eye. Moreover, we had previously validated the result that the catecholamine content in the adrenal gland of the CAP-treated rats was no different from that of normal rats.
17)
Measurement of adrenaline secretion from the adrenal gland. Adrenaline secretion in response to the chemicals was measured from the adrenal vein of anesthetized rats by using a continuous blood sampling system as described previously. 13, 18) Briefly, a rat anesthetized with -chloralose and urethane (50 mg/kg and 500 mg/kg, i.p., respectively) was placed on a heated pad, and the rectal temperature was maintained at 36.5-37.5 C. At 5 min after injecting a 200-ml saline solution containing 500 IU/ml of heparin through the femoral vein, a catheter was inserted into the adrenal vein. Adrenal blood was collected in successive 2-min fractions, and the 2nd fraction was used to determine the baseline value. A test reagent (1 ml/kg of body weight) was dissolved in saline containing 2% (v/v) ethanol and 10% (v/v) Tween 80, and the mixture was injected into the femoral vein for 1 min. CN-acid was dissolved in only dimethyl sulfoxide (DMSO) instead of ethanol as it was insoluble in ethanol. Six fractions of adrenal venous blood were collected in 3-min fractions. Heparinized saline (500 IU/ml) equivalent to the amount of blood (130-170 ml/min) was continuously transfused into the femoral vein. C6 and ATR (1 and 5 mg/kg or 2 and 10 mg/kg, respectively) in saline containing 3% ethanol and 10% Tween 80 was injected 5 min before injecting the test reagent. As an internal standard, we added a 3,4-dihydroxybenzylamine solution (50 pmol) to the blood collected from the adrenal vein. Plasma was obtained by centrifugation and frozen until needed for an assay, after adding 10% (w/v) Na 2 S 2 O 5 (50 ml/ml of plasma). Catecholamines in the plasma were purified with activated alumina 24) and measured by high-performance liquid chromatography with electrochemical detection (HPLC-EC).
15)
Statistical analysis. All data are indicated as the mean AE SEM. The statistical analysis was mainly conducted by an unpaired t-test. In cases of the total amount of adrenaline secreted as a result of the vehicle, CAP, AITC, or CNA, the treatment effects were analyzed by one-way ANOVA (non-parametric), and differences between the means were tested by Dunnett's multiplecomparison test.
Results

TRPA1 agonist-induced adrenaline secretion
The intravenous administration of CAP (50 mg/kg; 0.16 mmol/kg) resulted in adrenaline secretion by the rats as mentioned in a previous paper (Fig. 1A and D) . 18) AITC (1-10 mg/kg and 10.1-101 mmol/kg) or CNA (5-10 mg/kg and 37.8-75.7 mmol/kg) increased the adrenaline secretion from the adrenal gland soon after their intravenous administration in a concentration-dependent manner (Fig. 1B and C) . A dose of 10 mg/kg of AITC and CNA markedly enhanced the total adrenaline secretion for 20 min after sample injection (Fig. 1D) .
The chemical structures of CN-OH and CN-acid are similar to that of CNA ( Fig. 2A ), but they induced very weak or no TRPA1 activity.
2) Hence, we examined the effects of CN-OH and CN-acid on adrenaline secretion. CN-OH (10 mg/kg, 67.5 mmol/kg, i.v.) and CN-acid (10 mg/kg, 74.5 mol/kg, i.v.) did not increase adrenaline secretion from adrenal gland in rats (Fig. 2B) . These results were correlated with the TRPA1 activity induced by CNA-related compounds.
Effects of the CAP treatment on AITC-and CNAinduced adrenaline secretion
We investigated the involvement of TRPA1-expressing sensory nerves in the AITC-and CNA-induced adrenaline secretion. Most TRPA1 was expressed on the TRPV1-expressing primary sensory neurons. 1, 9) On the other hand, it is known that a CAP pretreatment in a pharmacological dose produces selective degeneration or neurotransmitter depletion of primary afferent CAPsensitive neurons.
25) It has recently been reported that a neonatal CAP treatment of rats caused a remarkable decrease in the mRNA levels of both TRPV1 and TRPA1 in the dorsal root ganglion (DRG) neurons. 26) We therefore examined adrenaline secretion after the A, Chemical structure of CNA (cinnamaldehyde), CN-OH (cinnamyl alcohol), and CN-OH (cinnamic acid). B, Total adrenaline secretion for 20 min after an intravenous injection of a sample was measured as described in the materials and methods section. CNA and CN-OH were dissolved in saline containing 2% ethanol and 10% Tween 80, while CN-acid was dissolved in saline containing 2% DMSO and 10% Tween 80. Each value is the mean AE SEM (n ¼ 6). The asterisk indicates a significant difference versus each vehicle, p < 0:05.
AITC and CNA injections in CAP-treated rats that had lost the TRPV1-and probably TRPA1-expressing sensory neuron function. The administration of CAP (50 mg/kg, i.v.) did not induce adrenaline secretion in the CAP-treated rats, suggesting that CAP-sensitive afferent neurons were essential for CAP-induced adrenaline secretion (Fig. 3A and D) . This result is consistent with that in a previous study. 17) Similarly, AITCand CNA-induced adrenaline secretion was completely abolished in the CAP-treated rats (Fig. 3B, C and D) . It was therefore suggested that activation of the sensory nerve was indispensable for the adrenaline secretion by AITC and CNA.
Effect of cholinergic blockers on the AITC-and CNAinduced adrenaline secretion
We examined the effect of the adrenal sympathetic nerve on AITC-and CNA-induced adrenaline secretion. Activation of the adrenal sympathetic nerve promotes acetylcholine secretion from nerve endings, and acetylcholine acts on the muscarinic and nicotinic receptors of the adrenal medulla; finally these signals induce adrenaline secretion. 27, 28) We therefore investigated the effect of both cholinergic blockers (C6 and ATR) on AITCand CNA-induced adrenaline secretion.
Watanabe et al. have previously reported that enhanced adrenaline secretion by CAP mainly occurred through activation of the adrenal sympathetic nerve via the central nervous system. 15) In this study, we also confirmed that a pretreatment with cholinergic blockers (1 mg/kg of C6, i.v.; 5 mg/kg of ATR, i.v.) attenuated the CAP-induced adrenaline secretion in rats (Fig. 4A  and D) . Similarly, enhancement of the adrenaline secretion by an intravenous injection of 10 mg/kg of CNA was significantly decreased by the pretreatment with C6 and ATR (Fig. 4C and D) . Meanwhile, 10 mg/kg of AITC-induced adrenaline secretion was attenuated by double the dosage of C6 (2 mg/kg, i.v.) and ATR (10 mg/kg, i.v.) (Fig. 4B and D) . Therefore, activation of the adrenal sympathetic nerve via the central nervous system was involved in the enhancement of adrenaline secretion by AITC and CNA.
Discussion
In traditional Chinese and Indian medicine, it is said that pungent foods such as hot pepper, ginger, mustard, and cinnamon warm the body. However, there is very little scientific evidence for these effects. It has been indicated in related reports that an intake of CAP increased adrenaline secretion and energy consumption via activation of the TRPV1-expressing primary sensory nerves. 11, 18) We focused here on the TRPA1 activation by AITC and CNA, and evaluated the enhancement of adrenaline secretion induced by these compounds as an index of the energy metabolism or thermogenesis by using rats.
Kawada et al. have previously demonstrated that CAP (650 nmol, i.v.) induced adrenaline secretion, but that the same dose of AITC (650 nmol, i.v.) did not. 19) Since this report, TRPV1 and TRPA1 have been cloned, and the effective concentrations (EC) 50 of CAP, AITC, and CNA for their receptors have been suggested. The EC 50 values of AITC and CNA for recombinant mouse TRPA1 have been reported to be 22 mM and 61 mM, 2) respectively, suggesting that these values are approximately 1000 times higher than the EC 50 values (33.9 nM) of CAP for recombinant rat TRPV1. 29) We therefore used a high dose of AITC and CNA rather than CAP in these experiments. Intravenous administration of AITC (10 mg/kg) and CNA (10 mg/kg) induced adrenaline secretion from the adrenal gland in anesthetized rats. These injection doses (mole) of AITC and CNA were approximately 600 times that of the 0.05 mg/kg (0.16 mmol/kg) CAP dose; thus, these results roughly indicate the TRP channel-activation potency. On the other hand, in the case of CN-OH (10 mg/kg) and CN-acid (10 mg/kg), the TRPA1 activity was very weak or nonexistent 2) and did not produce any increase in adrenaline secretion, although their structures are similar to that of CNA. These results were correlated with the TRPA1 activity. TRPA1 is mainly coexpressed with TRPV1 in DRG. 1, 9) AITC and CNA could not enhance adrenaline secretion in the CAP-treated rats in which the function of the CAPsensitive neuron or TRPA1 was impaired; 25, 26) this result suggests that the expression of TRPV1 and TRPA1 in the sensory nerves is essential for the enhancement of adrenaline secretion from the adrenal gland by ATIC and CNA. Rat TRPV1 was not activated by AITC and CNA in human embryonic kidney (HEK) 293 or Chinese hamster ovary (CHO) cells that expressed TRPV1 heterologously. 1, 2, 30) Moreover, TRPA1 knockout mice showed a deficit in Ca 2þ uptake by trigeminal neurons and irritant behavior in response to AITC. 31) Therefore, the activation of TRPA1 in the nerve may be associated with the enhancement of adrenaline secretion by AITC or CNA. It is necessary to get direct evidence for TRPA1 activation and adrenaline secretion by using TRPA1 knockout mice or specific TRPA1 antagonists.
In general, it is known that there are at least two mechanisms underlying drug-induced adrenaline secretion from the adrenal gland. One involves activation of the central nervous system that leads to adrenal efferent nerve enhancement, as observed in the case of CAP. 15) The other involves direct action of the drug on the adrenal gland as observed in the case of histamine and bradykinin. 27) In this study, cholinergic blockers (C6 and ATR) depressed the adrenaline secretion induced by AITC and CNA, suggesting that sympathetic nerve activity was clearly involved in the adrenaline secretion.
We have reported that the activation of TPPV1 by CAP enhanced adrenaline secretion from the adrenal gland. 18) Adrenaline increases the energy consumption and thermogenesis via activation of the -adrenergic receptor. 32, 33) It has been confirmed that the CAPinduced increase in oxygen consumption, plasma glucose, and thermogenesis was significantly attenuated in adrenal-demedullated rats, 14, 16) suggesting that adrenaline from the adrenal gland was very important for these effects. Moreover, activation of adrenergic receptor in brown adipose tissue (BAT), which is the organ responsible for heat production, increased the expression of uncoupling protein 1 (UCP1), a key molecule responsible for BAT thermogenesis. [34] [35] [36] In fact, CAP intake has increased the expression of UCP1 protein in rats. 37) On the other hand, it has been reported that the TRPA1 agonist, AITC, increased thermogenesis and the expression of UCP1. 37, 38) These effects are similar to the above-mentioned effects in the case of CAP; thus, AITC-induced adrenaline secretion might be related to the increase in thermogenesis and expression of UCP1 as already mentioned. However, not only adrenaline secretion, but also other mechanisms involving neurotransmitters such as noradrenaline from the end of sympathetic neurons, are involved in the increase in energy metabolism or thermogenesis. It is necessary to examine the other mechanisms involved in the increase in energy metabolism or thermogenesis by the administration of a TRPA1 agonist.
In conclusion, this study has demonstrated that the TRPA1 agonists, AITC and CNA, increased adrenaline secretion via activation of the sensory nerves expressing TRPA1 and adrenal sympathetic nerves in rats. Some spices found in alliaceous and cruciferous vegetables have ingredients that activate TRPA1, and these foods have traditionally been consumed to generate body warmth in Asia. Adrenaline secretion via the intake of a TRPA1 agonist might be one of explanations for the diet-induced thermogenesis caused by these foods.
